Local 12: Breakthrough device guides surgeons in locating breast cancer tumors
Local 12 highlighted research from the University of Cincinnati Cancer Center that found a seed device that acts as a GPS for surgeons to locate and remove breast and lymph node tumors was safe and effective.
UC's Jaime Lewis, MD, a Cancer Center physician-researcher and associate professor of surgery in the UC College of Medicine, said use of the SmartClip devices improves efficiency since radiologists can schedule the implantation when it works best for them, and then the day of surgery is also shorter.
"They can be put in the day before surgery, they can be put in three months before surgery,” Lewis told Local 12.
Watch or read the Local 12 story.
Read more about the UC research.
Featured photo at top of the SmartClip and introducer. Photo courtesy of Elucent.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.